Skip to content

Clinical trials

Diabetic Nephropathies trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Country / region: Taiwan Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20061
20101
20111
20131
20143
20152
20172
20191
20201
20211
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status4
Not yet recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
National Taiwan University Hospital3
AstraZeneca2
Boehringer Ingelheim2
Chang Gung Memorial Hospital2
AbbVie (prior sponsor, Abbott)1
Abbott1
Asia Diabetes Foundation1
China Medical University Hospital1
GenMont Biotech Incorporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies21
Diabetes Mellitus, Type 27
Renal Insufficiency, Chronic7
Proteinuria3
Diabetes Mellitus2
Hypertension2
Kidney Diseases2
Albuminuria1
Diabetic Neuropathies1
Diabetic Retinopathy1

Trials

Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.